{
    "clinical_study": {
        "@rank": "74068", 
        "brief_summary": {
            "textblock": "To evaluate the effects of three preparations of low-dose oral interferon alpha (i.e.,\n      Alferon LDO, Veldona, and Ferimmune) on HIV symptoms in HIV-infected patients. To evaluate\n      differences in response to oral interferon alpha according to gender, race/ethnicity, and\n      use of antiretrovirals.\n\n      Previous or ongoing clinical trials to test the efficacy of low-dose oral interferon alpha\n      have produced different results, and it is not clear whether the differences were due to the\n      interferon alpha products used or to problems in the study design.  Therefore, three\n      preparations will be compared to evaluate their potential efficacies."
        }, 
        "brief_title": "A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3", 
        "completion_date": {
            "#text": "June 2002", 
            "@type": "Actual"
        }, 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Previous or ongoing clinical trials to test the efficacy of low-dose oral interferon alpha\n      have produced different results, and it is not clear whether the differences were due to the\n      interferon alpha products used or to problems in the study design.  Therefore, three\n      preparations will be compared to evaluate their potential efficacies.\n\n      Patients are randomized to receive 6 months of Alferon LDO alone, Alferon with Veldona,\n      Alferon with Ferimmune, or three placebos, with follow-up visits monthly."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  Symptomatic HIV infection.\n\n          -  CD4 count 50 - 350 cells/mm3.\n\n        Prior Medication:\n\n        Allowed:\n\n          -  Prior antiretrovirals (dose must be stable for at least 6 weeks prior to study\n             entry).\n\n          -  Maintenance therapy for a chronic condition.\n\n        Exclusion Criteria\n\n        Patients with the following prior condition are excluded:\n\n          -  Change in antiretroviral therapy within past 6 weeks.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Oral IFN-alpha or other immune-based therapy within the past month.\n\n          -  Therapy for any acute disease within the past week."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": "560", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000844", 
            "org_study_id": "DATRI 022", 
            "secondary_id": "11727"
        }, 
        "intervention": [
            {
                "intervention_name": "Interferon alfa-n3", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Interferon alfa-n1", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Adjuvants, Immunologic", 
                "Interferon-alpha", 
                "Interferon Alfa-2a", 
                "Interferons"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Drug Therapy, Combination", 
            "Adjuvants, Immunologic", 
            "Administration, Oral", 
            "Acquired Immunodeficiency Syndrome", 
            "AIDS-Related Complex", 
            "Interferon-alpha"
        ], 
        "lastchanged_date": "May 21, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90059"
                    }, 
                    "name": "King - Drew Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Redwood City", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94063"
                    }, 
                    "name": "AIDS Community Research Consortium"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Haven", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "065102483"
                    }, 
                    "name": "Yale Univ / New Haven"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wilmington", 
                        "country": "United States", 
                        "state": "Delaware", 
                        "zip": "19801"
                    }, 
                    "name": "Med Ctr of Delaware / Wilmington Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20019"
                    }, 
                    "name": "Abundant Life Clinic Foundation"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20059"
                    }, 
                    "name": "Howard Univ Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20007"
                    }, 
                    "name": "Georgetown Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48202"
                    }, 
                    "name": "Henry Ford Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55455"
                    }, 
                    "name": "Univ of Minnesota Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brooklyn", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11203"
                    }, 
                    "name": "SUNY / Health Sciences Ctr at Brooklyn"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10031"
                    }, 
                    "name": "Dr Barbara Justice"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10037"
                    }, 
                    "name": "Harlem AIDS Treatment Group / Harlem Hosp Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valhalla", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10595"
                    }, 
                    "name": "New York Med College / Westchester County Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "Univ of Pennsylvania Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37208"
                    }, 
                    "name": "Meharry Med College"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3", 
        "overall_official": [
            {
                "last_name": "Alston B", 
                "role": "Study Chair"
            }, 
            {
                "last_name": "Standiford H", 
                "role": "Study Chair"
            }, 
            {
                "last_name": "Kumi J", 
                "role": "Study Chair"
            }, 
            {
                "last_name": "Greaves W", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "reference": [
            {
                "PMID": "11363808", 
                "citation": "Randall P. Low-dose oral alpha interferon study opens. NIAID AIDS Agenda. 1996 Jun;:4-5. No abstract available."
            }, 
            {
                "PMID": "11364607", 
                "citation": "[No authors listed] Low-dose oral alpha interferon trial closes. NIAID AIDS Agenda. 1997 Aug;:10. No abstract available."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000844"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "10634196", 
            "citation": "Alston B, Ellenberg JH, Standiford HC, Muth K, Martinez A, Greaves W, Kumi J. A multicenter, randomized, controlled trial of three preparations of low-dose oral alpha-interferon in HIV-infected patients with CD4+ counts between 50 and 350 cells/mm(3). Division of AIDS Treatment Research Initiative (DATRI) 022 Study Group. J Acquir Immune Defic Syndr. 1999 Dec 1;22(4):348-57."
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Endpoint Classification: Efficacy Study, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2012"
    }, 
    "geocoordinates": {
        "AIDS Community Research Consortium": "37.485 -122.236", 
        "Abundant Life Clinic Foundation": "38.895 -77.036", 
        "Dr Barbara Justice": "40.714 -74.006", 
        "Georgetown Univ Med Ctr": "38.895 -77.036", 
        "Harlem AIDS Treatment Group / Harlem Hosp Ctr": "40.714 -74.006", 
        "Henry Ford Hosp": "42.331 -83.046", 
        "Howard Univ Hosp": "38.895 -77.036", 
        "King - Drew Med Ctr": "34.052 -118.244", 
        "Med Ctr of Delaware / Wilmington Hosp": "39.746 -75.547", 
        "Meharry Med College": "36.166 -86.784", 
        "New York Med College / Westchester County Med Ctr": "41.075 -73.775", 
        "SUNY / Health Sciences Ctr at Brooklyn": "40.653 -73.959", 
        "Univ of Minnesota Hosp": "44.98 -93.264", 
        "Univ of Pennsylvania Med Ctr": "39.952 -75.164", 
        "Yale Univ / New Haven": "41.308 -72.928"
    }
}